Cutler Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,400
| Closed | -$1K | – | 4984 |
|
|
2022
Q4 | $1K | Sell |
1,400
-3,700
| -73% | -$52.4K | ﹤0.01% | 4242 |
|
|
2022
Q3 | $5K | Sell |
5,100
-1,700
| -25% | -$27.4K | ﹤0.01% | 3729 |
|
|
2022
Q2 | $54K | Sell |
6,800
-21,500
| -76% | -$344K | ﹤0.01% | 1901 |
|
|
2022
Q1 | $66K | Buy |
+28,300
| New | +$443K | ﹤0.01% | 2024 |
|
|
2020
Q2 | – | Sell |
-300
| Closed | -$11K | – | 5050 |
|
|
2020
Q1 | $11K | Sell |
300
-7,300
| -96% | -$656K | ﹤0.01% | 2688 |
|
|
2019
Q4 | $4K | Sell |
7,600
-17,100
| -69% | -$1.53M | ﹤0.01% | 3195 |
|
|
2019
Q3 | $255K | Buy |
24,700
+22,200
| +888% | +$1.49M | 0.02% | 595 |
|
|
2019
Q2 | $90K | Sell |
2,500
-8,400
| -77% | -$752K | 0.01% | 1155 |
|
|
2019
Q1 | $164K | Buy |
10,900
+5,800
| +114% | +$634K | 0.02% | 749 |
|
|
2018
Q4 | $237K | Buy |
5,100
+1,500
| +42% | +$155K | 0.02% | 553 |
|
|
2018
Q3 | $108K | Buy |
3,600
+2,000
| +125% | +$212K | 0.01% | 1156 |
|
|
2018
Q2 | $49K | Buy |
+1,600
| New | +$117K | ﹤0.01% | 1626 |
|
|
2018
Q1 | – | Sell |
-11,600
| Closed | -$329K | – | 5438 |
|
|
2017
Q4 | $329K | Sell |
11,600
-12,400
| -52% | -$782K | 0.01% | 716 |
|
|
2017
Q3 | $646K | Sell |
24,000
-12,500
| -34% | -$1.35M | 0.02% | 523 |
|
|
2017
Q2 | $102K | Buy |
36,500
+200
| +0.6% | +$23.2K | ﹤0.01% | 1849 |
|
|
2017
Q1 | $300K | Sell |
36,300
-141,600
| -80% | -$16.5M | 0.01% | 906 |
|
|
2016
Q4 | $1.35M | Buy |
177,900
+92,900
| +109% | +$11.1M | 0.05% | 312 |
|
|
2016
Q3 | $2.27M | Buy |
85,000
+9,500
| +13% | +$1.5M | 0.1% | 142 |
|
|
2016
Q2 | $2.97M | Sell |
75,500
-4,300
| -5% | -$627K | 0.15% | 101 |
|
|
2016
Q1 | $3.99M | Buy |
79,800
+3,500
| +5% | +$413K | 0.26% | 48 |
|
|
2015
Q4 | $3.5M | Buy |
+76,300
| New | +$12.9M | 0.2% | 80 |
|
Cutler Group's ICPT Position: Q4 2023 in Review
Cutler Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 17,800 shares — an estimated $330K sold.
Cutler Group first reported a position in ICPT in Q4 2015 and held it in 30 quarters. The position peaked at $2.49M in Q4 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Cutler Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Cutler Group sold 17,800 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $330K.
- Cutler Group first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 30 quarters.
- Cutler Group's Intercept Pharmaceuticals, Inc. position peaked at $2.49M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.